Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated revision tag indicating a small maintenance update to the page's metadata and versioning.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small update or correction to the study page. This reflects an internal version bump rather than a substantive addition to study content or user-facing features.SummaryDifference0.0%

- Check42 days agoChange DetectedA new revision tag, v3.6.2, was added and the old tag, v3.6.0, was removed. This indicates a minor update to the page's underlying system rather than changes to the study content.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays a recruitment status note ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), while the Intervention/Treatment heading is standardized and the Revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check63 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a small metadata update to the ClinicalTrials.gov entry.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This indicates a minor update to the page’s template/metadata without changing the study content or user-facing details.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.